A Prospective, Single-Blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Peripheral Vascular Surgery.

Grants and Contracts Details

StatusFinished
Effective start/end date5/29/12 → 5/31/14

Funding

  • Grifols Biologicals Inc: $23,606.00